Search research articles
Contact Us
Filters
Showing results (201-210 of 280) with videos related to
Page
of 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Phase I pharmacokinetic study of the novel antitumor agent SR233377
P M LoRusso, B J Foster, A Wozniak, et al.
Cancer
|
September 14, 2012
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma
Sapna P Patel, Alexander J Lazar, Nicholas E Papadopoulos, et al.
Cancer Research Communications
|
May 12, 2025
First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors
Benedito A Carneiro, Olumide B Gbolahan, Albiruni Abdul Abdul Razak, et al.
Investigational New Drugs
|
September 8, 2018
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer
Laura W Goff, Nilofer S Azad, Stacey Stein, et al.
Investigational New Drugs
|
October 19, 2018
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer
Laura W Goff, Nilofer S Azad, Stacey Stein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors
Toshio Shimizu, Patricia M LoRusso, Kyri P Papadopoulos, et al.
British Journal of Cancer
|
March 23, 2016
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies
Joaquin Mateo, David Olmos, Herlinde Dumez, et al.
Scientific Reports
|
May 25, 2021
Improved methods for RNAseq-based alternative splicing analysis
Rebecca F Halperin, Apurva Hegde, Jessica D Lang, et al.
Nature Neuroscience
|
December 22, 1999
A cultural effect on brain function
E Paulesu, E McCrory, F Fazio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2012
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432
Patricia M LoRusso, Karthik Venkatakrishnan, Ramesh K Ramanathan, et al.
Page
of 28
Search research articles
Search
Showing results (201-210 of 280) with videos related to
Sort By:
Page
of 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Phase I pharmacokinetic study of the novel antitumor agent SR233377
P M LoRusso, B J Foster, A Wozniak, et al.
Cancer
|
September 14, 2012
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma
Sapna P Patel, Alexander J Lazar, Nicholas E Papadopoulos, et al.
Cancer Research Communications
|
May 12, 2025
First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors
Benedito A Carneiro, Olumide B Gbolahan, Albiruni Abdul Abdul Razak, et al.
Investigational New Drugs
|
September 8, 2018
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer
Laura W Goff, Nilofer S Azad, Stacey Stein, et al.
Investigational New Drugs
|
October 19, 2018
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer
Laura W Goff, Nilofer S Azad, Stacey Stein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors
Toshio Shimizu, Patricia M LoRusso, Kyri P Papadopoulos, et al.
British Journal of Cancer
|
March 23, 2016
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies
Joaquin Mateo, David Olmos, Herlinde Dumez, et al.
Scientific Reports
|
May 25, 2021
Improved methods for RNAseq-based alternative splicing analysis
Rebecca F Halperin, Apurva Hegde, Jessica D Lang, et al.
Nature Neuroscience
|
December 22, 1999
A cultural effect on brain function
E Paulesu, E McCrory, F Fazio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2012
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432
Patricia M LoRusso, Karthik Venkatakrishnan, Ramesh K Ramanathan, et al.
Page
of 28